ENGLISH

Rick Simpson Oil (RSO) in Georgia: The Complete Guide by OilWell Cannabis

Why RSO Matters in Georgia

Georgia’s relationship with cannabis has evolved significantly in recent years, though the legal landscape remains complex. While the state has made strides with medical cannabis programs, many Georgians still face barriers to accessing high-quality, full-spectrum cannabis products that could potentially support their health and wellness goals.

This is where Rick Simpson Oil (RSO) enters the conversation. Named after the Canadian activist who popularized concentrated cannabis oil as a potential therapeutic option, RSO has become a sought-after product among Georgians dealing with chronic conditions, pain management, and other health challenges. However, the quality, safety, and legality of RSO products available in Georgia can vary dramatically.

At OilWell Cannabis, we believe Georgians deserve access to the best possible version of RSO—one that combines the traditional benefits of full-spectrum cannabis with modern scientific advancements, rigorous testing, and complete transparency. This guide will walk you through everything you need to know about RSO in Georgia, from its origins to how our products are designed to meet the unique needs of Georgians.

Understanding Rick Simpson and Traditional RSO

Who Was Rick Simpson?

Rick Simpson was a Canadian power engineer who became one of the most influential figures in the modern cannabis movement. Born in 1949 in Nova Scotia, Simpson’s journey into cannabis advocacy began after a workplace accident in 1997 left him with persistent post-concussion symptoms, including tinnitus and dizziness. When conventional medications failed to provide relief, Simpson turned to cannabis, which he found more effective than anything his doctors prescribed.

Simpson’s interest in cannabis deepened after he learned about a 1974 study conducted at the Medical College of Virginia, where researchers found that THC could slow or shrink tumors in mice. Though these findings were never replicated in controlled human trials, they became a foundational reference point for Simpson’s later work.

The pivotal moment in Simpson’s story came in 2003 when he claimed that three bumps on his arm—diagnosed as basal cell carcinoma—disappeared after he applied concentrated cannabis oil to the lesions and covered them with bandages. According to Simpson, the bumps were gone within four days. While this account lacks independent medical verification or clinical documentation, it became the origin story of what we now know as Rick Simpson Oil (RSO).

The Birth of a Movement

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil. Operating from his property in Maccan, Nova Scotia, he began making large quantities of the oil and giving it away for free to cancer patients and others in his community. Simpson charged nothing for his oil, believing that cannabis should be accessible to everyone who needed it.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, featured testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. Distributed freely online, Run From The Cure became one of the most widely shared cannabis advocacy films of its era and introduced millions of people—including many in Georgia—to the concept of concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005, seizing plants and equipment. Despite community support and public attention, Simpson was raided again in 2009, facing charges of cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, where he continued his advocacy from abroad.

Traditional RSO: What It Was and Why It Matters

Traditional RSO refers to the specific type of concentrated cannabis oil that Simpson made and advocated for. Unlike modern, lab-tested cannabis products, traditional RSO was defined by Simpson’s method and materials rather than by standardized specifications or regulatory standards. Here’s what you need to know about how it was made:

Source Material

Simpson used high-THC, indica-dominant cannabis strains, favoring heavy, sedating genetics. He grew his own cannabis or sourced it from trusted growers, but there was no strain standardization—the starting material varied by availability and growing season.

Extraction Solvent

Simpson originally used naphtha—a petroleum-based solvent commercially available as lighter fluid or similar products. Later, he also endorsed 99% isopropyl alcohol as an alternative. Neither naphtha nor isopropyl alcohol is food-grade, which poses significant safety concerns, particularly regarding residual solvents.

Extraction Process

1. Preparation: Dry or semi-dry cannabis plant material was placed in a container (typically a bucket).
2. Solvent Wash: The material was covered with solvent and agitated or stirred for several minutes to dissolve cannabinoids and other fat-soluble compounds.
3. Filtration: The solvent was poured off through a filter (such as cheesecloth) into a separate collection vessel.
4. Second Wash: The process was repeated with fresh solvent on the same plant material to extract remaining cannabinoids.
5. Evaporation: The combined solvent washes were placed in a rice cooker or similar open-vessel heating device to evaporate the solvent at relatively low heat.
6. Final Product: As the solvent evaporated, a thick, dark oil remained at the bottom of the vessel. This oil was transferred into oral syringes for storage and dosing.

Appearance and Characteristics

Traditional RSO was an extremely dark—nearly black—thick, viscous, tar-like oil. It had a strong cannabis odor and could carry a faint solvent-residual smell, depending on how thoroughly the solvent was purged. The consistency was sticky and difficult to handle at room temperature but became more fluid when warmed slightly.

Cannabinoid Profile

• THC-Dominant: Traditional RSO was fully decarboxylated, meaning the heat involved in solvent evaporation converted essentially all THCa in the extract into delta-9 THC. This made it an activated, THC-dominant product, with estimated THC content ranging from 60% to 90% by weight.
• Minor Cannabinoids: Whatever CBD, CBN, CBC, CBG, and other minor cannabinoids the source strain contained were present at their natural ratios, but these were not controlled, measured, or targeted.
• No Ratio Control: There was no ability to adjust or standardize specific cannabinoid ratios. The profile was entirely determined by the genetics and growing conditions of the source plant.

Terpene Content

Traditional RSO had minimal to no terpene content. The combination of solvent extraction and high-heat evaporation destroyed terpenes, which are volatile aromatic compounds with relatively low boiling points. This meant that traditional RSO was effectively a cannabinoid-only product, despite being derived from a terpene-rich plant.

Standardization and Testing

Traditional RSO was not standardized or lab-tested. Every batch was different because it depended entirely on the starting plant material, growing conditions, solvent purity, extraction technique, evaporation temperature and duration, and the individual maker’s process. There was no Certificate of Analysis (COA), no cannabinoid quantification, and no contaminant screening.

Residual Solvent Risk

This is one of the most significant safety concerns with traditional RSO production. Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha, in particular, is a complex mixture of petroleum hydrocarbons that may contain benzene, toluene, and other compounds classified as toxic or carcinogenic. Incomplete solvent purging—difficult to verify without lab testing—leaves potentially harmful residues in the finished oil.

Simpson’s Protocol: The 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams (approximately 60 mL) of concentrated cannabis oil over a period of roughly 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions. Here’s a detailed breakdown of the protocol as Simpson described it:

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration Schedule

• Week 1: Begin with a dose approximately the size of half a grain of dry rice—roughly 10 to 15 milligrams of oil—taken three times per day (morning, afternoon, and before bed). Total daily intake during this phase: approximately 30 to 45 milligrams. Simpson emphasized that the initial doses should be very small to allow the body to begin adjusting to the psychoactive effects of THC.

• Weeks 2 through 5: Double the dose approximately every four days. The purpose of the slow ramp-up was to build THC tolerance gradually and minimize disruption from the psychoactive effects. By the end of this escalation period—roughly four to five weeks in—the target was to reach approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses.

• Weeks 5 through 12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, and continue until the full 60 grams have been consumed. At this dosing level, the remaining 50-plus grams of oil would be consumed over the final seven to eight weeks.

Administration Methods

• Primary Method (Oral): Simpson recommended placing the dose directly under the tongue (sublingual) or swallowing it. He considered oral ingestion the most important route for systemic absorption and the primary method for internal cancers and other systemic conditions.
• Secondary Method (Topical): For skin cancers and external lesions, Simpson recommended applying the oil directly to the affected area, covering it with a bandage, and changing the bandage every three to four days. He combined topical application with oral dosing for skin cancers.
• Not Recommended as Primary (Inhalation): Simpson did not recommend smoking or vaporizing the oil as a primary treatment method. He acknowledged inhalation for immediate symptom relief (pain, nausea) but maintained that the oral route was necessary for the sustained, high-dose exposure he considered therapeutically essential.

Tolerance and Psychoactive Effects

• Simpson maintained that patients would develop significant tolerance to the psychoactive effects of THC within approximately three to four weeks of consistent dosing at escalating levels.
• He considered the euphoric, sedating, or disorienting effects a minor and temporary side effect and strongly urged patients not to let the “high” discourage them from continuing the protocol.
• He recommended that patients take their initial doses at night or before bed to sleep through the most intense psychoactive effects during the early titration phase.
• Simpson also recommended that patients avoid driving or operating machinery during the titration period and that they inform family members about what to expect.

Post-Protocol Maintenance

• After completing the full 60-gram course, Simpson recommended a maintenance dose of approximately 1 to 2 grams of oil per month, taken indefinitely.
• He considered this ongoing low-dose maintenance important for long-term health and cancer prevention.
• Simpson indicated that maintenance dosing was much lower than the treatment dose and that patients who had completed the full protocol would have sufficient THC tolerance to handle it comfortably.

Dietary and Lifestyle Recommendations

Simpson also advocated for dietary changes alongside the oil protocol, including reducing sugar intake, avoiding processed foods, and improving overall nutrition. However, his dietary advice was general and not as systematically detailed as his oil protocol.

Important Context for Evaluating Simpson’s Protocol

It’s crucial to understand that Simpson’s protocol was designed by one person based on his personal experience and anecdotal observations. It was not developed through clinical trials, dose-finding studies, pharmacokinetic modeling, or any formal research process. Here are several critical points to consider:

• No Controlled Trial Validation: There are no published randomized controlled trials, cohort studies, or even well-documented case series evaluating this specific 60-gram/90-day protocol for any cancer type or any other condition.

• Assumes Crude, Unstandardized Material: The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content per gram of traditional RSO varied widely depending on the starting plant material and extraction technique.

• Very High THC Exposure: At the peak dosing phase, patients were consuming roughly 1 gram of high-THC oil per day. Assuming traditional RSO contained 60% to 90% THC, this translates to approximately 600 to 900 milligrams of delta-9 THC per day—a dose far exceeding anything studied in controlled clinical settings. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 milligrams per day.

• Real Risks at These Doses: Consuming 600 to 900 milligrams of THC daily carries serious risks, including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in the scientific literature.

• Oncology Context: Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment—potentially in place of proven therapies—introduces harm that extends beyond the oil itself. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative-medicine literature.

Simpson’s Claims vs. the Evidence Record

Rick Simpson made expansive therapeutic claims about his oil. He stated that RSO could cure cancer—including terminal cases—and that it was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions. He was adamant, consistent, and public about these claims throughout his advocacy career.

However, it’s important to evaluate these claims against the actual evidence base, using the same standards applied throughout this document.

What Simpson Was Not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted his results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally—with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the Preclinical Literature Shows

The preclinical cannabinoid-cancer literature does exist, and it is scientifically interesting:

• In vitro studies have demonstrated that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis (blood vessel formation that feeds tumors) in certain cancer cell lines.
• Animal model studies have shown some tumor-growth inhibition in mice and rats treated with cannabinoids.
• These findings have generated legitimate scientific interest and ongoing research.

What the Preclinical Literature Does Not Show

• These findings have not translated into proven human cancer cures. The gap between in vitro or animal results and human clinical outcomes is vast, well-documented across all of oncology research, and especially relevant here.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they have been exploratory, small, and have not produced the kind of results that would support cancer-cure claims.

Institutional Positions

• The U.S. National Cancer Institute (NCI) acknowledges that cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment.
• The U.S. Food and Drug Administration (FDA) has not approved any cannabis plant product for the treatment of cancer. The only FDA-approved cannabinoid-related products are for other specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting.
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• The National Center for Complementary and Integrative Health (NCCIH) explicitly states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and appetite-related indications in HIV/AIDS—not cancer cure.

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or actively suppressing that conversation. His advocacy—however scientifically imprecise—helped create the political, cultural, and social conditions for the legal cannabis industry and the cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term “RSO” itself remains the most recognized name for full-spectrum cannabis extract in the consumer vocabulary. These contributions are real and historically significant.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients—particularly cancer patients—to rely on RSO as a primary treatment in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative-medicine literature. Simpson’s absolute certainty about curative claims, while understandable from a personal-experience perspective, exceeded what the evidence could support and still exceeds it today.

The Legacy of Rick Simpson and the Evolution of Modern RSO

The term “RSO” is now used broadly—and often loosely—across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract sold in a syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use. The term has become generic.

Simpson himself has been critical of commercial products that use the RSO name while departing significantly from his original method and philosophy. He has publicly stated that many products sold as RSO do not meet his standards and that the commercialization of cannabis oil contradicts his original intent. Simpson’s model was explicitly anti-commercial—he gave the oil away for free and urged others to make their own rather than buy from companies.

This philosophical tension is worth acknowledging. Simpson believed in a do-it-yourself, free-access model in which anyone could grow cannabis, extract the oil, and treat themselves or their loved ones without corporate or governmental intermediaries. The modern cannabis industry has done something very different: it has commercialized, standardized, and regulated what Simpson distributed for free. Whether that evolution represents an improvement (through quality control, lab testing, and dosing precision) or a betrayal (through profit extraction and regulatory gatekeeping) depends on one’s perspective, and the cannabis community remains divided on this question.

What is not in dispute is that modern RSO has evolved substantially from its origins, and those changes are directly relevant to the formulas in this document.

Why OilWell’s Formulas Diverge from Traditional RSO

At OilWell Cannabis, we respect the legacy of Rick Simpson and the movement he helped inspire. However, our formulations are not traditional RSO. They are informed by the RSO tradition but depart from it in several deliberate, evidence-motivated ways that address the limitations of Simpson’s original approach. Here’s how and why our formulas are different:

1. Multi-Cannabinoid Approach

Traditional RSO: Relied on whatever single strain the maker grew or sourced. The cannabinoid profile was entirely determined by the genetics and growing conditions of the source plant, with no ability to adjust or standardize specific cannabinoid ratios.

OilWell RSO: Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity. While robust clinical proof of whole-formula synergy remains limited, the inclusion of multiple cannabinoids allows us to target different therapeutic pathways simultaneously.

For Georgians dealing with complex conditions like chronic pain, inflammation, or sleep disorders, a multi-cannabinoid approach may offer broader support than a single-cannabinoid product. For example:

• CBD is well-documented for its anti-inflammatory and anxiolytic properties.
• CBG shows promise for neuroprotection and gut health.
• Delta-8 THC provides a milder psychoactive experience than delta-9 THC, which may be preferable for some users.
• THCa offers non-psychoactive anti-inflammatory benefits when used raw.
• CBN is often associated with sleep support.
• CBC has been studied for its potential role in neurogenesis and pain relief.

2. Terpene Preservation and Addition

Traditional RSO: Had essentially no terpene content due to solvent and heat destruction. The finished oil was a cannabinoid-only product, despite being derived from a terpene-rich plant.

OilWell RSO: Our formulas include live terpenes at 5% with a specific seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each of these terpenes has its own evidence profile and potential benefits:

• Limonene: Known for its citrus-bright aroma, limonene may support mood and stress relief.
• Myrcene: Often associated with relaxation and sedation, myrcene may enhance the calming effects of cannabinoids.
• Caryophyllene: A unique terpene that acts as a CB2 receptor agonist, caryophyllene may support anti-inflammatory and pain-relief pathways.
• Pinene: With a forest-fresh aroma, pinene may promote alertness and respiratory health.
• Linalool: Known for its floral, lavender-like scent, linalool may support relaxation and sleep.
• Humulene: With an earthy, woody aroma, humulene may have anti-inflammatory properties.
• Terpinolene: Often described as piney, fruity, and sparkling, terpinolene may contribute to the overall sensory experience and potential entourage effects.

For Georgians who appreciate the sensory aspects of cannabis—whether in the form of oils, edibles, or vapes—terpenes enhance the overall experience while potentially contributing to the therapeutic effects.

3. THCa as a Separate Ingredient

Traditional RSO: Fully decarboxylated everything, converting all THCa into delta-9 THC. The finished oil was always psychoactive, with no option for non-psychoactive use.

OilWell RSO: Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor to THC. This is an intentional formulation choice informed by the THCa evidence profile, which suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC.

For Georgians who need to function during the day—whether for work, driving, or parenting—this design allows for non-psychoactive use. The customer decides whether to use the oil raw (non-psychoactive) or to decarboxylate it at home (psychoactive) by heating it at 260°F (125°C) for 45 to 60 minutes. This patient-controlled potency is one of the most significant innovations in modern RSO.

4. Reduced Delta-9 THC Dominance

Traditional RSO: Overwhelmingly delta-9 THC—often 60% to 90% of total cannabinoid content. This high THC exposure carried significant risks, including impairment, anxiety, and dependency.

OilWell RSO: Our sublingual formula uses delta-9 THC at only 90 mg (3 mg per mL) while incorporating delta-8 THC at 6,000 mg (200 mg per mL). The remaining cannabinoid content is distributed across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model.

For Georgians who are sensitive to the psychoactive effects of THC or who need to avoid impairment for work or other responsibilities, this balanced approach offers a safer and more manageable experience.

5. Product Format Innovation

Traditional RSO: Envisioned only one format: an oral oil administered from a syringe. This limited patients to a single delivery method with a slow onset and long duration.

OilWell RSO: We offer two product formats, each designed for different use cases and pharmacokinetic profiles:

• RSO Sublingual Oil: A 30 mL bottle containing 16,590 mg of total cannabinoids (553 mg per mL). This format is ideal for sustained relief, precise dosing, and daytime non-psychoactive use when kept raw.
• RSO Vape Cartridge: A 1-gram cartridge containing 900 mg+ of total cannabinoids. This format is designed for fast relief (1-2 minute onset) and is particularly useful for acute symptoms like breakthrough pain, nausea, or anxiety.

For Georgians with varying needs—whether for chronic pain management, sleep support, or acute symptom relief—having multiple formats provides flexibility and convenience.

Solvent Safety and Extraction Evolution

One of the most significant improvements in modern RSO production is the elimination of toxic solvents. Traditional RSO production used naphtha or isopropyl alcohol—neither of which is food-grade. Naphtha, in particular, is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, xylene, and other compounds with established toxicity. Isopropyl alcohol, while cleaner than naphtha, is also not intended for internal consumption. Incomplete solvent purging—difficult to verify without analytical chemistry equipment—leaves potentially harmful residues in the finished oil.

Modern cannabis extraction overwhelmingly uses food-grade ethanol or supercritical carbon dioxide (CO₂). These methods allow for much more complete solvent removal, and the finished products can be tested for residual solvents using validated analytical methods such as headspace gas chromatography. This is one of the most straightforward improvements that the modern regulated cannabis industry has made over the traditional RSO production model.

At OilWell Cannabis, our RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha, no isopropyl alcohol, no butane, and no extraction solvents are present in the finished product. This approach eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production.

Our product uses organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile—a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through the OilWell website.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. The heat involved in evaporating solvent from the rice cooker—typically sustained at or near the boiling point of the solvent—was sufficient to convert essentially all THCa in the extract into delta-9 THC. This conversion is thermodynamically favored and proceeds readily at these temperatures over the durations involved in solvent evaporation.

As a result, the acidic cannabinoids that exist abundantly in raw cannabis plant material—including THCa, CBDa, CBGa, and others—were lost as distinct compounds in traditional RSO. The finished oil was a decarboxylated, activated product dominated by neutral (non-acidic) cannabinoids.

OilWell’s sublingual formula deliberately preserves THCa at 1,500 mg as a separate ingredient. This is an intentional formulation choice informed by the THCa evidence profile, which notes that THCa itself does not produce the psychoactive effects associated with THC but that its interpretation depends on route, temperature, processing, and storage—because THCa can convert to THC under heating or over time.

This design creates three distinct usage options for the customer:

Option 1: Raw, No Heat

All 1,500 mg of THCa stays in its acidic, non-psychoactive form. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism. This option is compatible with work, driving, and daytime use with zero psychoactive impairment.

For Georgians who need to manage chronic pain, inflammation, or other symptoms without the risk of impairment, this is a game-changer. Whether you’re a professional who needs to stay sharp during the day, a parent managing household responsibilities, or someone who simply prefers to avoid the psychoactive effects of THC, the raw option provides a way to experience the potential benefits of RSO without the “high.”

Option 2: Fully Activated, Home Decarboxylation

Heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC already in the formula, this yields approximately 1,405 mg of total delta-9 THC. Combined with 6,000 mg of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional high-THC RSO—100% legally, because decarboxylation occurs at the customer’s discretion after purchase.

The customer may also transfer a controlled portion of the oil from the original bottle into a second empty oven-safe glass container, decarboxylating only what they intend to use and preserving the remainder in its raw THCa form.

For Georgians who want the full therapeutic potential of RSO—including the psychoactive effects for conditions like insomnia, chronic pain, or appetite stimulation—this option provides the flexibility to activate the oil as needed. This is particularly valuable for those who prefer to use higher-potency cannabis products in the evening or for specific therapeutic purposes.

Option 3: Vape, Auto-Decarboxylation

The RSO Vape Cartridge vaporizes at 400 to 450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available, with effects felt within 1-2 minutes.

For Georgians dealing with acute symptoms like breakthrough pain, panic attacks, or nausea, the vape cartridge provides immediate relief. The fast onset and short duration make it ideal for situations where quick symptom management is needed without long-lasting effects.

The Conversion Chemistry

THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg of THCa = 0.877 mg of delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in the customer’s hands—aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than a one-size-fits-all approach.

Terpene Loss in Traditional RSO and Why It Matters

Terpenes are volatile aromatic compounds with relatively low boiling points. Most cannabis terpenes begin to volatilize at temperatures between 21°C and 157°C, with many of the most abundant terpenes—including myrcene, limonene, and pinene—having boiling points below 180°C. The traditional RSO production process destroyed terpenes in two ways: first, by dissolving them into the solvent wash along with cannabinoids; and second, by evaporating them off during the high-heat solvent-removal phase.

This meant that traditional RSO was essentially a cannabinoid-only product, despite being derived from a terpene-rich plant. Whatever aromatic, flavoring, or potentially bioactive terpene compounds the source cannabis contained were lost in production.

OilWell’s formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each of these terpenes has its own evidence profile, and the entourage-effect literature provides the theoretical framework for why preserving and including terpenes alongside cannabinoids may matter pharmacologically, even though robust human clinical proof of cannabis-specific entourage effects remains limited.

Why Terpenes Matter for Georgians

For Georgians who appreciate the sensory and therapeutic aspects of cannabis, terpenes enhance the overall experience in several ways:

1. Flavor and Aroma: Terpenes give cannabis its distinctive flavors and aromas. Whether you prefer the citrus notes of limonene, the earthy tones of humulene, or the floral hints of linalool, terpenes make the experience more enjoyable and personalized.

2. Potential Therapeutic Benefits: While the evidence for terpenes’ therapeutic effects is still emerging, preclinical and anecdotal reports suggest that they may contribute to the overall effects of cannabis. For example:

   • Limonene is often associated with mood enhancement and stress relief.
   • Myrcene is believed to promote relaxation and sedation.
   • Caryophyllene may support anti-inflammatory and pain-relief pathways.
   • Pinene is thought to promote alertness and respiratory health.
   • Linalool is often linked to relaxation and sleep support.

3. Entourage Effect: The entourage effect is the theory that cannabinoids and terpenes work together synergistically to produce more significant effects than any single compound alone. While this theory is still being studied, many Georgians report that full-spectrum products with terpenes provide a more balanced and effective experience than isolated cannabinoids.

Evidence Standards Then and Now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. When he began making and distributing oil in the early 2000s, cannabis was illegal in Canada and throughout most of the world. There was no regulatory framework for cannabis products, no standardized testing infrastructure, no legal pathway for clinical research on cannabis oil protocols, and no peer-reviewed journals dedicated to cannabis therapeutics. The cannabis underground was the only access point, and personal experience was the primary evidence currency.

Simpson’s methods reflected the constraints of that era. His evidence was anecdotal. His production was unstandardized. His claims were untested in any formal sense. This is not necessarily a moral failing—it is a description of the environment in which he operated.

This document takes a fundamentally different approach. The GENERAL KNOWLEDGE section applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews and meta-analyses, then institutional summaries, then preclinical and mechanistic literature. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled. The intent is to honor the historical origin of RSO while committing to the standards of modern cannabinoid science. Where Simpson relied on personal testimony, this document relies on published literature and institutional sources.

For Georgians who value evidence-based medicine, this approach provides a level of transparency and credibility that is often lacking in the cannabis industry. Whether you’re a patient exploring RSO for the first time or a healthcare provider looking for reliable information to share with your patients, this evidence-based framework ensures that you have access to the most accurate and up-to-date information available.

Simpson’s Protocol vs. Modern Dosing Considerations

Simpson’s 60-gram/90-day protocol was designed around a crude, single-strain, THC-dominant extract with no standardized potency. A direct comparison between Simpson’s dosing recommendations and dosing with a modern, standardized, multi-cannabinoid formulation is not straightforward—the products are fundamentally different.

Several key differences illustrate why:

• Cannabinoid Concentration: OilWell’s sublingual formula delivers 553 mg of total active cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.

• Cannabinoid Ratios: Simpson’s oil was approximately 60% to 90% delta-9 THC. OilWell’s formula distributes 16,590 mg of total cannabinoids across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), and CBC (750 mg)—a completely different pharmacologic profile.

• Terpene Presence: Simpson’s oil had no terpenes. OilWell’s formula includes live terpenes at 5%, which may influence absorption, effect, and tolerability.

• Delta-9 THC Exposure: Simpson’s protocol at peak dosing delivered approximately 600 to 900 mg of delta-9 THC per day. OilWell’s sublingual formula contains only 90 mg of delta-9 THC in the entire 30 mL bottle (3 mg per mL), making the per-dose delta-9 THC exposure dramatically lower.

Future dosing guidance for OilWell products should be developed independently of Simpson’s protocol, informed by the per-compound evidence in the GENERAL KNOWLEDGE section and by responsible titration principles that account for the safety profile of each individual cannabinoid. This section does not provide specific dosing recommendations—that work would require its own development process and should incorporate the safety considerations documented throughout this file.

However, here are some general principles to keep in mind when using OilWell RSO in Georgia:

Start Low, Go Slow

Whether you’re using the sublingual oil or the vape cartridge, it’s important to start with a low dose and gradually increase until you find the amount that works best for you. This approach minimizes the risk of adverse effects and allows you to tailor the experience to your specific needs.

• Sublingual Oil: Begin with 0.25 to 0.5 mL (approximately 138 to 276 mg of total cannabinoids) and wait at least 2 to 3 hours to assess the effects before increasing the dose. The onset of effects typically occurs within 15 to 45 minutes, with peak effects reached within 1 to 2 hours.

• Vape Cartridge: Start with 1 to 2 puffs and wait at least 10 to 15 minutes to assess the effects before taking additional puffs. The onset of effects is rapid (1 to 2 minutes), with peak effects reached within 10 to 15 minutes.

Consider Your Goals

The optimal dose of OilWell RSO depends on your specific goals and the condition you’re trying to address. Here are some general guidelines based on the evidence profiles of the individual cannabinoids:

• Chronic Pain: For daytime pain management without psychoactive effects, start with 0.3 to 0.5 mL of raw sublingual oil (non-decarboxylated). For nighttime pain relief with potential sleep support, consider 0.5 to 1.0 mL of decarboxylated sublingual oil or a few puffs from the vape cartridge.

• Sleep Support: For improved sleep, consider 1.0 to 2.0 mL of sublingual oil before bed. At 2.0 mL, this delivers 50 mg of CBN—the dosage level investigated in recent sleep literature. At 1.0 mL, this delivers 25 mg of CBN, which is above the 20 mg threshold associated with reduced sleep disturbance in published research.

• Anxiety and Stress: For daytime anxiety relief without psychoactive effects, start with 0.3 mL of raw sublingual oil. For evening use, consider 1.0 mL of sublingual oil or a few puffs from the vape cartridge.

• Chemotherapy-Related Nausea: For nausea and appetite support, consider 0.5 to 1.0 mL of sublingual oil approximately 1 hour before treatment. For acute breakthrough nausea, the vape cartridge provides immediate relief (1-2 minute onset).

Listen to Your Body

Everyone’s endocannabinoid system is unique, and individual responses to cannabinoids can vary significantly. Factors such as body weight, metabolism, tolerance, and concurrent medications can all influence how you respond to OilWell RSO. Pay attention to how you feel and adjust your dose accordingly.

Consult a Healthcare Provider

Before using OilWell RSO—or any cannabinoid product—it’s important to consult with a qualified healthcare provider, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Cannabinoids can interact with certain medications, and your healthcare provider can help you determine whether OilWell RSO is a safe and appropriate option for you.

OilWell Cannabis: The Story Behind the Science

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin’s journey into the world of cannabis is deeply personal and rooted in his experiences growing up along the U.S.-Mexico border in McAllen, Texas.

McAllen is part of the Borderplex region, which includes Reynosa, Tamaulipas, Mexico. This area is known for its vibrant culture and economic activity, but it’s also one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Reynosa, in particular, is an industrial hub plagued by violence and cartel activity, making it a harsh environment for anyone growing up there.

Colin’s childhood in McAllen was marked by exposure to both the opportunities and the challenges of life along the border. From a young age, he learned to navigate the complexities of the region, taking on work that exposed him to the dangers and realities of life in that environment. Many of his best friends were killed or imprisoned due to the associated risks, and by the age of sixteen, Colin had to leave home for good to escape the cycle of violence.

Despite the dangers, Colin didn’t fall into the darker paths available to him, such as selling harder substances. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. This combination of deep cannabis plant knowledge and medical-grade technical precision would eventually define OilWell’s approach to product development.

Bentley’s Story: The Heart of OilWell Cannabis

The origin story of OilWell Cannabis begins with a dog named Bentley. Bentley wasn’t just a pet—he was family, a loyal companion who stood by Colin through some of the toughest times in his life. When Bentley fell seriously ill, veterinarians delivered a devastating verdict: euthanasia was the only humane option. Bentley was paralyzed in his back legs, and the pain medications prescribed by the veterinarians were expected to destroy his internal organs, causing more pain and suffering. The choice was between a painful, prolonged decline or immediate mercy killing.

But giving up on Bentley wasn’t an option for Colin. He had already faced too much loss and seen too much suffering in his life. Bentley was a fighter, just like him, and Colin wasn’t ready to let him go. In a desperate search for alternatives, he stumbled upon the healing properties of CBD—through a question that would change everything.

A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had plenty of experience with cannabis, but it had always been recreational—getting high. He had never explored the therapeutic and medicinal applications of the plant. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline, and it was hope. And that hope delivered something that veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. This wasn’t a placebo effect—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at the age of twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration: Led Colin to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
• Dementia: Led him to explore CBC’s role in neurogenesis.
• Glaucoma: Led him to study THC’s CB1 agonism for intraocular pressure reduction.
• Crippling Arthritis: Led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into the world of cannabis beyond just getting high. It became a mission to create real solutions that help alleviate pain and suffering—not just for pets, but for people as well. Bentley’s story is the foundation of OilWell Cannabis, driving its commitment to quality, innovation, and compassionate care.

From Personal Struggle to Public Mission

Colin’s personal experiences with cannabis extend beyond Bentley. He also knows the challenges of pharmaceutical dependence firsthand. Colin struggled with PTSD and benzodiazepine addiction, and when he decided to break free from Xanax, he did it cold turkey—a feat that is notoriously difficult and dangerous. Using the cannabinoid knowledge he had developed while keeping Bentley alive, Colin created the Peace Gummies formula during midnight experiments while fighting through benzo withdrawal.

To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This isn’t theoretical knowledge—Colin has lived what many RSO patients live: desperation for relief, failed pharmaceuticals, and the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Media Recognition: Houston’s Go-To Cannabis Authority

Colin Valencia and OilWell Cannabis have been featured in seven comprehensive news segments by ABC13 Houston (KTRK), the ABC affiliate serving America’s fourth-largest city. These segments, spanning from 2019 to 2023, cover a wide range of topics, including Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in Houston, a testament to his deep knowledge and credibility in the field.

Here are some highlights from the media coverage:

1. Texas CBD Businesses Booming (September 2019): Colin’s foundational quote—“I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”—captures the philosophy that drives OilWell’s approach to education and transparency.

2. Entrepreneur Creates Direct-to-Consumer Business (March 2021): This segment highlights Colin’s role as an ecosystem builder, helping other entrepreneurs like Jonathan Pina enter the legal cannabis space. Colin’s quote—“People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”—reflects his understanding of the therapeutic potential of cannabis.

3. What Is Delta-8 THC? (May 2021): This investigative segment became one of the most widely referenced ABC13 cannabis features. Colin’s radical honesty—“I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*—demonstrates his commitment to transparency and authenticity, even on mainstream television.

4. Houston CBD Shop Giving Away Free Products for COVID Vaccine (August 2021): This segment documented OilWell’s most significant community health initiative—donating approximately $35,000 in product (1,000 caviar pre-rolls) to encourage COVID-19 vaccination. The giveaway was hosted in partnership with HydroShack Hydroponics, a retail partner in The Heights, and demonstrated OilWell’s commitment to community health and well-being.

5. Texas Ban Over Delta-8 Raises Questions (October 2021): This segment captured a defining moment in OilWell’s story. When the legal landscape shifted overnight and Delta-8 was classified as a Schedule I substance, Colin proactively removed all Delta-8 products from his shelves before enforcement began. He also warned other operators who were unknowingly shipping what had overnight become Schedule I narcotics. This ethical leadership during a regulatory crisis demonstrated OilWell’s commitment to integrity and responsible business practices.

6. Biden Marijuana Pardon (October 2022): This segment revealed that Colin has a personal marijuana conviction history, adding a deeply personal dimension to his story. Colin’s quote—“I would love to see people not get hurt for this anymore.”—reflects his commitment to criminal justice reform and his belief in the therapeutic and social potential of cannabis.

7. Marijuana Industry Getting Creative (April 2023): This segment, published the day after 4/20, completed a four-year arc of media coverage. Colin’s “Renaissance” framing—“Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”—reflects his vision for the future of cannabis in Texas and beyond.

The OilWell RSO Philosophy: Four Core Principles

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in ways that are deliberate, evidence-motivated, and designed to solve the problems that limited Rick Simpson’s original vision. Four core principles define OilWell’s approach, each aligning with and evolving Simpson’s original ethos:

1. Accessibility Over Gatekeeping

Simpson’s Vision: Simpson believed medicine should be accessible to everyone. He gave his oil away for free and taught people how to make it themselves.

OilWell’s Approach: No medical card is required. Anyone age 21 or older can purchase OilWell RSO. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson wanted medicine to be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For Georgians, this means no barriers to entry. Whether you’re in Atlanta, Savannah, Augusta, or a rural community, you can access OilWell RSO without needing a medical card or visiting a dispensary. Our same-day delivery in Houston and nationwide shipping ensure that Georgians can get the products they need, when they need them.

2. Patient-Controlled Potency

Simpson’s Vision: Simpson believed patients should control their own medicine. He encouraged them to follow his protocol and make their own decisions about dosing.

OilWell’s Approach: THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed in patient control; we engineered a product that puts that control in the customer’s hands through chemistry rather than rhetoric.

For Georgians, this means flexibility. Whether you need to manage symptoms during the day without impairment or want the full therapeutic potential of activated THC in the evening, you have the power to choose. This patient-controlled potency is particularly valuable in a state like Georgia, where access to high-quality cannabis products can be limited.

3. Open-Source Formulas

Simpson’s Vision: Simpson gave his oil away for free and taught people how to make it. He never patented his method and never charged patients.

OilWell’s Approach: We publish our complete RSO formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who cannot afford our products can source the ingredients and make their own version. Simpson gave his oil away for free; we adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

For Georgians who may not be able to afford our products, this open-source approach ensures that no one is left behind. We believe that access to high-quality cannabis products should not be limited by financial constraints, and our open-source formulas empower Georgians to take control of their health and wellness.

4. Evidence-Informed, Not Evidence-Overstating

Simpson’s Vision: Simpson operated without access to peer-reviewed literature or clinical trial data. His evidence was based on personal experience and testimonials.

OilWell’s Approach: The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what the science actually says. Simpson operated without access to modern research; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

For Georgians, this means access to the most accurate and up-to-date information available. Whether you’re a patient exploring RSO for the first time or a healthcare provider looking for reliable information to share with your patients, our evidence-informed approach ensures that you have the tools you need to make informed decisions.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill (Agricultural Improvement Act) legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of OilWell’s RSO product design and enables us to ship our products nationwide and internationally.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids in the formula are hemp-derived. The product is legal under federal law and in most states, including Georgia.

The THCa Advantage

THCa—tetrahydrocannabinolic acid—is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance of this framework is substantial. The customer can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC in the formula, this produces approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at the customer’s discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). The customer controls the decision. The product is legal everywhere all component cannabinoids are legal, which enables international shipping to jurisdictions where hemp-derived products with less than 0.3% delta-9 THC are permitted.

Important Legal Notice for Georgians

THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with their local laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal responsibility.

In Georgia, the legal landscape for hemp-derived products is still evolving. While the 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC at the federal level, state laws can vary. It’s important for Georgians to stay informed about the latest regulations and to ensure that they are in compliance with both federal and state laws when purchasing and using OilWell RSO.

Open-Source Formulas: Why OilWell Publishes Everything

At OilWell Cannabis, we believe in transparency and accessibility. That’s why we publish our complete RSO formulas—every cannabinoid, every milligram amount, every percentage—in public documents, including this one. The RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed in full later in this document.

The rationale is straightforward: if someone cannot afford OilWell’s products—$129.99 for the sublingual oil, $49.99 for the vape cartridge—they can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make their own version. The formulas in the RSO Sublingual Oil and RSO Vape Cartridge sections of this document are the open-source formulas.

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. He never patented his method. He never charged patients. We adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

As Colin Valencia said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The open-source philosophy didn’t start with RSO—it started with Bentley. On the About Us page, Colin published the actual CBD golden paste recipe that saved Bentley’s life, so that any pet owner facing a similar crisis could make it themselves:

CBD Golden Paste Recipe for Pets: The Original Open-Source Formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on the size and needs of the pet; consult with a veterinarian)

Instructions:

1. Mix the turmeric and water: In a saucepan, combine the turmeric powder and water, stirring over low heat. Stir continuously until it forms a thick paste. This should take about 7 to 10 minutes. Add a little more water if it becomes too thick.
2. Add the coconut oil and pepper: Once you have a thick paste, add the coconut oil and freshly ground black pepper. Stir until all ingredients are thoroughly mixed.
3. Cool and store: Allow the paste to cool, then transfer it to a jar with a lid. Store it in the refrigerator for up to two weeks.
4. Dosage: Add a small amount of CBD oil to the paste before giving it to the pet, adjusting the dosage based on their weight and health needs. Start with a low dose and gradually increase as needed.

Serving Suggestion: Mix a small amount of the golden paste with the pet’s food once or twice a day. Monitor the pet for any changes and consult with a veterinarian if there are any concerns. Always consult with a veterinarian before starting any new supplement regimen for a pet.

This recipe—published for free, years before the RSO formulas were open-sourced—demonstrates that the pattern is consistent. Colin gave away the formula that saved Bentley before he gave away the formula designed for people. The open-source ethos is not a marketing strategy. It is the foundational behavior of the company.

For Georgians, this open-source approach means that no one is left behind. Whether you can afford our products or not, you have access to the information you need to make informed decisions about your health and wellness. We believe that everyone deserves the opportunity to explore the potential benefits of cannabis, and our open-source formulas make that possible.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving the patient with no choice about psychoactivity—the oil was always psychoactive.

OilWell’s sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for the customer, each with its own benefits and applications:

Option 1: Raw, No Heat

All 1,500 mg of THCa stays in its acidic, non-psychoactive form. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism. This option is compatible with work, driving, and daytime use with zero psychoactive impairment.

For Georgians who need to manage chronic pain, inflammation, or other symptoms without the risk of impairment, this is a game-changer. Whether you’re a professional who needs to stay sharp during the day, a parent managing household responsibilities, or someone who simply prefers to avoid the psychoactive effects of THC, the raw option provides a way to experience the potential benefits of RSO without the “high.”

Option 2: Fully Activated, Home Decarboxylation

Heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC already in the formula, this yields approximately 1,405 mg of total delta-9 THC. Combined with 6,000 mg of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional high-THC RSO—100% legally, because decarboxylation occurs at the customer’s discretion after purchase.

The customer may also transfer a controlled portion of the oil from the original bottle into a second empty oven-safe glass container, decarboxylating only what they intend to use and preserving the remainder in its raw THCa form.

For Georgians who want the full therapeutic potential of RSO—including the psychoactive effects for conditions like insomnia, chronic pain, or appetite stimulation—this option provides the flexibility to activate the oil as needed. This is particularly valuable for those who prefer to use higher-potency cannabis products in the evening or for specific therapeutic purposes.

Option 3: Vape, Auto-Decarboxylation

The RSO Vape Cartridge vaporizes at 400 to 450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available, with effects felt within 1 to 2 minutes.

For Georgians dealing with acute symptoms like breakthrough pain, panic attacks, or nausea, the vape cartridge provides immediate relief. The fast onset and short duration make it ideal for situations where quick symptom management is needed without long-lasting effects.

The Conversion Chemistry

THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg of THCa = 0.877 mg of delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in the customer’s hands—aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than a one-size-fits-all approach.

Solvent-Free Production: Safety and Quality You Can Trust

OilWell’s RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha, no isopropyl alcohol, no butane, and no extraction solvents are present in the finished product.

This approach eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production, as discussed earlier in this document.

Our product uses organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile—a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-Party Lab Testing: Ensuring Safety and Transparency

At OilWell Cannabis, we believe that transparency is key to building trust with our customers. That’s why we subject our products to rigorous third-party lab testing, covering the following areas:

1. Cannabinoid Potency: We test for the presence and concentration of all cannabinoids in our products, including CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC. This ensures that our products contain the exact amounts of cannabinoids listed on the label.

2. Terpene Profile: We test for the presence and concentration of all terpenes in our products, including limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. This ensures that our terpene profiles are consistent and accurately represented.

3. Pesticides: We test for the presence of over 400 different pesticides to ensure that our products are free from harmful chemical residues.

4. Heavy Metals: We test for the presence of heavy metals, including arsenic, cadmium, lead, and mercury, to ensure that our products are safe for consumption.

5. Residual Solvents: We test for the presence of residual solvents to ensure that our products are free from any harmful residues left over from the extraction process.

6. Microbial Contaminants: We test for the presence of microbial contaminants, including E. coli, Salmonella, and Aspergillus, to ensure that our products are free from harmful bacteria and fungi.

Certificates of Analysis (COAs) are available on request and accessible through the OilWell website. These COAs provide detailed information about the results of our lab tests, giving you the peace of mind that comes with knowing exactly what’s in your product.

Why Solvent-Free Production Matters for Georgians

For Georgians who are concerned about the safety and quality of cannabis products, our solvent-free production process offers several key benefits:

1. Eliminates Residual Solvent Risk: By using a formulated blend of individual cannabinoid distillates and isolates, we eliminate the risk of residual solvents in our products. This ensures that you’re getting a clean, safe product every time.

2. Improves Taste and Consistency: Our use of organic MCT oil as a carrier base provides a neutral taste profile, making our products more enjoyable to use. The consistency is also improved, with a smooth, easy-to-administer oil that’s free from the tar-like texture of traditional RSO.

3. Enhances Absorption: MCT oil is known for its ability to enhance the absorption of cannabinoids through sublingual tissue. This means that you may experience faster onset and more consistent effects when using our products.

4. Supports Overall Health: MCT oil is a food-grade lipid carrier that is easily metabolized by the body. It provides a source of quick energy and may support overall health and well-being.

The Broader OilWell Product Portfolio: Beyond RSO

While RSO is one of our flagship products, OilWell Cannabis offers a range of cannabinoid products designed to meet the diverse needs of Georgians. Each product is developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzodiazepine withdrawal.

Asshole Peach: The Most Popular Product

Asshole Peach is OilWell’s most popular product, and for good reason. It’s a carefully formulated experience designed to provide a euphoric, long-lasting sensation that’s particularly favored by veterans for its ability to relieve pain and PTSD symptoms without being overly aggressive.

• Cannabinoid Profile: Asshole Peach contains 268 mg of total cannabinoids per ring, including 28 mg of delta-9 THC, 50 mg of delta-8 THC, 20 mg of delta-10 THC, 20 mg of THCo, 100 mg of CBD, and 50 mg of CBG.
• Flavor: Peach
• Effects: Euphoric, relaxing, pain-relieving
• Ideal For: Veterans, chronic pain sufferers, and anyone looking for a balanced, enjoyable cannabis experience.

Peace Gummies: Sleep and Recovery Support

Peace Gummies were developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. They helped him quit Xanax cold turkey and are now available in both gummy and vape forms for quick relief.

• Cannabinoid Profile: Peace Gummies contain 320 mg of total cannabinoids per peach, including 30 mg of CBN, 15 mg of delta-9 THC, 25 mg of delta-8 THC, 100 mg of CBD, and 150 mg of CBG.
• Flavor: Peach
• Effects: Relaxing, sleep-inducing, anxiety-relieving
• Ideal For: Insomnia, PTSD, anxiety, and anyone looking for a natural way to unwind and relax.

Colin personally uses the vape form of Peace Gummies to manage his insomnia and severe PTSD on an ongoing basis. This firsthand experience ensures that the product is designed to meet the needs of those dealing with similar challenges.

SWEETEMintz: Sugar-Free Vegan Peppermint Hard Candy

SWEETEMintz is a sugar-free, vegan peppermint hard candy designed for diabetic and health-conscious consumers. It offers a discreet and convenient way to enjoy the benefits of cannabinoids without sugar or animal products.

• Cannabinoid Profile: Each candy contains 28 mg of delta-9 Nano THC, 100 mg of Nano CBD, and 50 mg of CBG Isolate.
• Flavor: Peppermint
• Effects: Refreshing, uplifting, discreet
• Ideal For: Diabetics, vegans, health-conscious consumers, and anyone looking for a sugar-free, portable cannabinoid option.

Custom Creations: Tailored to Your Needs

At OilWell Cannabis, we understand that every individual is unique, and so are their health and wellness needs. That’s why we offer custom-made products tailored to the specific needs of our customers. Whether it involves specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, we design targeted products on request.

This includes formulations for:

• Vegans: Products made without any animal-derived ingredients.
• Diabetics: Sugar-free options that won’t spike blood sugar levels.
• Specific Health Needs: Custom formulations for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and more.

For Georgians with unique health challenges or dietary restrictions, our custom creations provide a way to access the benefits of cannabis in a way that works for them.

Two Product Formats: Sublingual Oil and Vape Cartridge

OilWell offers the RSO formula in two delivery formats, each designed for different use cases and pharmacokinetic profiles. This flexibility ensures that Georgians can choose the format that best meets their needs, whether for sustained relief, fast onset, or precise dosing.

RSO Sublingual Oil: $129.99

• Format: 30 mL bottle (1 fl oz)
• Total Cannabinoids: 16,590 mg (553 mg per mL)
• Cannabinoid Profile:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Terpene Profile: Live terpenes at 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier Base: Organic MCT oil
• Dosing: Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes (sublingual absorption through oral mucosa)
• Peak Effects: 1 to 2 hours
• Duration: 4 to 6 hours
• Bioavailability: 13% to 19% (sublingual route partially bypasses first-pass liver metabolism)
• Doses per Bottle: Approximately 40 to 60 doses, depending on serving size

Why Georgians Choose the Sublingual Oil

• Sustained Relief: Ideal for chronic conditions like pain, inflammation, and sleep disorders.
• Precise Dosing: The graduated dropper allows for accurate dosing, making it easy to find the right amount for your needs.
• Daytime Use: When kept raw (non-decarboxylated), the oil provides non-psychoactive benefits, making it suitable for daytime use.
• Nighttime Use: When decarboxylated, the oil provides full psychoactive potency, making it ideal for nighttime use and sleep support.
• Versatility: Can be used sublingually, added to food or beverages, or applied topically (though it’s designed for sublingual use).

RSO Vape Cartridge: $49.99

• Format: 1-gram cartridge
• Total Cannabinoids: 900 mg+
• Cannabinoid Profile: Same six-cannabinoid ratio as the sublingual formula (no delta-9 THC listed separately—THCa auto-decarbs at vaping temperature)
• Terpene Profile: Live terpenes at 5%+
• Compatibility: 510-thread universal battery compatibility
• Onset: 1 to 2 minutes (fastest cannabinoid delivery method)
• Peak Effects: 10 to 15 minutes
• Duration: 2 to 4 hours
• Bioavailability: 10% to 35% (variable, dependent on inhalation technique)
• Auto-Decarboxylation: THCa converts to delta-9 THC instantly at vaping temperature (400 to 450°F)

Why Georgians Choose the Vape Cartridge

• Fast Relief: Ideal for acute symptoms like breakthrough pain, nausea, or anxiety.
• Portability: Compact and discreet, making it easy to use on the go.
• Discretion: No measuring required, and the effects are short-lived, making it ideal for situations where discretion is important.
• Convenience: No need to decarboxylate—every puff delivers freshly activated cannabinoids.

When to Use Each Format: A Guide for Georgians

Choosing the right format depends on your specific needs and lifestyle. Here’s a quick guide to help you decide which OilWell RSO product is right for you:

Use Case	Recommended Format	Rationale
Fast Relief (acute pain, nausea, panic)	Vape Cartridge	1-2 minute onset
Sustained Relief (chronic pain, sleep)	Sublingual Oil	4-6 hour duration
Maximum Bioavailability	Sublingual Oil	13-19% absorption
Portability and Discretion	Vape Cartridge	Compact, no measuring required
Precise Dosing Control	Sublingual Oil	Graduated dropper in 0.1 mL increments
Daytime Non-Psychoactive Use	Sublingual Oil (raw, no heat)	THCa stays inactive, zero impairment
Nighttime Psychoactive Use	Sublingual Oil (decarbed) or Vape Cartridge	Activated THCa + delta-8 THC

Condition-Specific Usage Contexts for Georgians

While OilWell RSO is not intended to diagnose, treat, cure, or prevent any disease, we understand that Georgians are using our products to support their health and wellness goals. Here are some general guidelines for using OilWell RSO based on specific conditions, informed by the evidence profiles of the individual cannabinoids in our formula:

Chemotherapy-Related Nausea and Appetite Support

• Pre-Chemo: 0.5 to 1.0 mL of sublingual oil approximately 1 hour before treatment.
• Acute Breakthrough Nausea: 2 to 3 puffs from the vape cartridge for immediate relief (1-2 minute onset).
• Post-Chemo: 0.5 mL of sublingual oil every 6 hours as needed.
• Sleep Support During Treatment: 1.0 to 2.0 mL of sublingual oil before bed (delivers 25 to 50 mg of CBN).
• Evidence Context: Delta-8 THC has been studied for its antiemetic properties, while delta-9 THC is well-documented for its ability to reduce nausea and vomiting. CBD may help buffer anxiety associated with chemotherapy.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL of raw sublingual oil—provides anti-inflammatory cannabinoid exposure without psychoactive impairment.
• Nighttime: 0.5 to 1.0 mL of decarboxylated sublingual oil—combines pain relief with CBN sleep support.
• Breakthrough Pain: Vape cartridge as needed for rapid onset.
• Evidence Context: CBD and delta-9 THC have both been studied for their pain-relieving properties. Beta-caryophyllene, a terpene in our formula, acts as a CB2 receptor agonist and may support anti-inflammatory pathways. THCa, when used raw, may also contribute to anti-inflammatory effects via COX-2 inhibition.

Sleep Support

• Before Bed: 1.0 to 2.0 mL of sublingual oil.
• At 2.0 mL: This delivers 50 mg of CBN—the dosage level investigated in recent sleep literature.
• At 1.0 mL: This delivers 25 mg of CBN—above the 20 mg threshold associated with reduced sleep disturbance in published research.
• Evidence Context: CBN is often associated with sleep support, and while the evidence is still emerging, many Georgians report improved sleep with CBN-containing products. The combination of CBN, CBD, and terpenes like myrcene and linalool may contribute to the overall sleep-promoting effects of our formula.

Anxiety and Stress

• Daytime Functional Relief: 0.3 mL of raw sublingual oil—CBD and CBG address anxiety-related pathways without psychoactive impairment.
• Nighttime: 1.0 mL of sublingual oil—full cannabinoid profile including CBN for sleep architecture.
• Evidence Context: CBD is well-documented for its anxiolytic properties. CBG has also been studied for its potential role in anxiety relief. Limonene, a terpene in our formula, may contribute to mood enhancement and stress relief.

General Titration Principle: Start Low, Go Slow

Whether you’re using the sublingual oil or the vape cartridge, it’s important to start with a low dose and gradually increase until you find the amount that works best for you. This approach minimizes the risk of adverse effects and allows you to tailor the experience to your specific needs.

• Sublingual Oil: Begin with 0.25 to 0.5 mL (approximately 138 to 276 mg of total cannabinoids) and wait at least 2 to 3 hours to assess the effects before increasing the dose. The onset of effects typically occurs within 15 to 45 minutes, with peak effects reached within 1 to 2 hours.

• Vape Cartridge: Start with 1 to 2 puffs and wait at least 10 to 15 minutes to assess the effects before taking additional puffs. The onset of effects is rapid (1 to 2 minutes), with peak effects reached within 10 to 15 minutes.

Listen to Your Body

Everyone’s endocannabinoid system is unique, and individual responses to cannabinoids can vary significantly. Factors such as body weight, metabolism, tolerance, and concurrent medications can all influence how you respond to OilWell RSO. Pay attention to how you feel and adjust your dose accordingly.

Consult a Healthcare Provider

Before using OilWell RSO—or any cannabinoid product—it’s important to consult with a qualified healthcare provider, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Cannabinoids can interact with certain medications, and your healthcare provider can help you determine whether OilWell RSO is a safe and appropriate option for you.

For Georgians, finding a cannabis-knowledgeable healthcare provider can be challenging, but resources like the Society of Cannabis Clinicians and Americans for Safe Access can help you locate providers in your area.

Delivery and Global Accessibility: Bringing RSO to Georgians

At OilWell Cannabis, we believe that access to high-quality cannabis products should not be limited by geography. That’s why we offer a range of delivery options to ensure that Georgians can get the products they need, when they need them.

Houston Same-Day Delivery

While our same-day delivery service is primarily focused on the Houston area, it’s worth mentioning as a testament to our commitment to accessibility. We offer free delivery to the Texas Medical Center—the world’s largest medical complex with over 10 million patient visits annually—reflecting our dedication to serving those who need our products the most.

Nationwide Shipping: Bringing RSO to Georgia

We ship OilWell RSO nationwide, including to Georgia. Here’s what you need to know about our shipping options:

• Shipping Methods: We use USPS Priority Mail (2 to 3 business days), FedEx, and UPS Ground (3 to 5 business days) to ensure that your order arrives quickly and safely.
• Discreet Packaging: All orders are shipped in discreet packaging with no cannabis branding visible. This ensures that your privacy is protected.
• Tracking: We provide tracking information for all orders, so you can monitor the progress of your shipment.
• Temperature-Stable Packaging: For summer shipments, we use temperature-stable packaging to ensure that your products arrive in optimal condition.
• Signature-Required Option: For an additional fee, you can choose to require a signature upon delivery.

International Shipping: Expanding Access Beyond Borders

OilWell Cannabis ships internationally and has already delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

Here’s what you need to know about international shipping:

• Documentation: All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.
• Shipping Costs: A minimum flat-fee shipping rate applies. Excessive international shipping costs are billed to the customer.
• Legal Responsibility: The customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk.
• Contact Information: For international orders, please contact us at (832) 416-2816 or [email protected].

The significance of international access cannot be overstated. Rick Simpson could not ship his oil anywhere—it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Germany, a chronic pain patient in Australia, or a veteran in the United Kingdom can now potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. OilWell built a product that can move across borders legally—completing a piece of Rick Simpson’s vision that prohibition made impossible during his lifetime of advocacy.

Why Accessibility Matters for Georgians

For Georgians, access to high-quality cannabis products can be a challenge. While the state has made progress with medical cannabis programs, many residents still face barriers to accessing the products they need. OilWell’s nationwide and international shipping options ensure that Georgians can access our products regardless of where they live.

Whether you’re in Atlanta, Savannah, Augusta, Macon, or a rural community, you can have OilWell RSO delivered directly to your door. This accessibility is particularly important for Georgians dealing with chronic conditions, pain management, or other health challenges that may not be adequately addressed by conventional treatments.

How the OilWell Formulas Connect to the Evidence

Every cannabinoid in OilWell’s formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—has its own evidence profile in the GENERAL KNOWLEDGE section of this document. Every terpene in OilWell’s formula—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—is also covered with preclinical and review-level evidence.

The formulas published in this document are not standalone product listings. They are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging from review and preclinical literature, and what is overstated relative to the current evidence base. Where OilWell’s RSO guide page makes specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

The Evidence Hierarchy: A Foundation of Trust

The GENERAL KNOWLEDGE section of this document applies a formal evidence hierarchy:

1. Human Clinical Evidence: The strongest form of evidence, derived from controlled human trials.
2. Systematic Reviews and Meta-Analyses: Comprehensive reviews of multiple studies, providing a broader perspective on the evidence.
3. Institutional Summaries: Summaries from reputable institutions like the National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
4. Preclinical and Mechanistic Literature: Animal studies, in vitro research, and mechanistic studies that provide foundational insights but are not yet confirmed in humans.

This hierarchy ensures that our claims are grounded in the most reliable and up-to-date scientific research available. For Georgians who value evidence-based medicine, this approach provides a level of transparency and credibility that is often lacking in the cannabis industry.

Cannabinoid Evidence Profiles: What the Science Says

Here’s a brief overview of the evidence profiles for the cannabinoids in OilWell’s RSO formula:

CBD (Cannabidiol)

• Best Supported: Epilepsy (particularly rare forms like Dravet syndrome and Lennox-Gastaut syndrome), anxiety, and pain.
• Emerging Evidence: Sleep, inflammation, and neuroprotection.
• Safety: Generally well-tolerated, but may interact with certain medications and cause side effects like diarrhea, fatigue, and changes in appetite.

CBG (Cannabigerol)

• Best Supported: Preclinical evidence suggests potential for neuroprotection, anti-inflammatory effects, and antibacterial activity.
• Emerging Evidence: Inflammatory bowel disease (IBD), glaucoma, and appetite stimulation.
• Safety: Limited human data, but generally considered safe in preclinical studies.

Delta-8 THC

• Best Supported: Psychoactive effects (milder than delta-9 THC), antiemetic properties (reducing nausea and vomiting).
• Emerging Evidence: Pain relief, anxiety reduction, and appetite stimulation.
• Safety: Generally considered safer than delta-9 THC due to its milder psychoactive effects, but more research is needed.

THCa (Tetrahydrocannabinolic Acid)

• Best Supported: Non-psychoactive anti-inflammatory effects (via COX-2 inhibition), neuroprotective potential (via PPARγ agonism).
• Emerging Evidence: Antiemetic properties, appetite stimulation, and potential anti-cancer effects (preclinical).
• Safety: Non-psychoactive when kept raw, but converts to delta-9 THC when heated, which may cause psychoactive effects.

Delta-9 THC

• Best Supported: Pain relief, nausea and vomiting (particularly in chemotherapy patients), appetite stimulation, and muscle spasticity (in multiple sclerosis).
• Emerging Evidence: Sleep, PTSD, and anxiety (though high doses may worsen anxiety).
• Safety: Psychoactive, may cause impairment, anxiety, paranoia, and dependency. Not recommended for individuals with a history of psychosis or substance use disorders.

CBN (Cannabinol)

• Best Supported: Preclinical evidence suggests potential for sleep support and neuroprotection.
• Emerging Evidence: Pain relief, anti-inflammatory effects, and appetite stimulation.
• Safety: Limited human data, but generally considered safe in preclinical studies.

CBC (Cannabichromene)

• Best Supported: Preclinical evidence suggests potential for neuroprotection, anti-inflammatory effects, and pain relief.
• Emerging Evidence: Antibacterial activity, neurogenesis, and potential anti-cancer effects (preclinical).
• Safety: Limited human data, but generally considered safe in preclinical studies.

Terpene Evidence Profiles: Enhancing the Experience

Terpenes are aromatic compounds found in cannabis and other plants that contribute to the plant’s flavor, aroma, and potential therapeutic effects. Here’s a brief overview of the evidence profiles for the terpenes in OilWell’s RSO formula:

Limonene

• Potential Benefits: Mood enhancement, stress relief, anti-inflammatory effects, and potential anti-cancer properties (preclinical).
• Aroma: Citrus-bright, reminiscent of lemons and oranges.

Myrcene

• Potential Benefits: Relaxation, sedation, anti-inflammatory effects, and potential pain relief.
• Aroma: Earthy, musky, with hints of cloves.

Caryophyllene (β-Caryophyllene)

• Potential Benefits: Anti-inflammatory effects (via CB2 receptor agonism), pain relief, and potential neuroprotective properties.
• Aroma: Peppery, spicy, with hints of cloves.

Pinene

• Potential Benefits: Alertness, respiratory health, anti-inflammatory effects, and potential neuroprotective properties.
• Aroma: Fresh, piney, reminiscent of pine forests.

Linalool

• Potential Benefits: Relaxation, sleep support, anti-anxiety effects, and potential pain relief.
• Aroma: Floral, lavender-like.

Humulene

• Potential Benefits: Anti-inflammatory effects, appetite suppression, and potential antibacterial properties.
• Aroma: Earthy, woody, with hints of hops.

Terpinolene

• Potential Benefits: Antioxidant effects, potential sedative properties, and potential anti-cancer effects (preclinical).
• Aroma: Piney, fruity, with a sparkling, fresh quality.

The Entourage Effect: The Whole Is Greater Than the Sum of Its Parts

The entourage effect is the theory that cannabinoids and terpenes work together synergistically to produce more significant effects than any single compound alone. While this theory is still being studied, many Georgians report that full-spectrum products with terpenes provide a more balanced and effective experience than isolated cannabinoids.

At OilWell Cannabis, we believe in the potential of the entourage effect, which is why our RSO formula includes a diverse range of cannabinoids and terpenes. This multi-compound approach allows us to target multiple therapeutic pathways simultaneously, providing a more comprehensive and potentially effective experience for Georgians.

Practical Takeaways for Georgians Using OilWell RSO

Here are some key takeaways to keep in mind when using OilWell RSO in Georgia:

1. Start Low, Go Slow

Whether you’re using the sublingual oil or the vape cartridge, it’s important to start with a low dose and gradually increase until you find the amount that works best for you. This approach minimizes the risk of adverse effects and allows you to tailor the experience to your specific needs.

2. Consider Your Goals

The optimal dose of OilWell RSO depends on your specific goals and the condition you’re trying to address. Here are some general guidelines based on the evidence profiles of the individual cannabinoids:

• Chronic Pain: Start with 0.3 to 0.5 mL of raw sublingual oil for daytime use. For nighttime use, consider 0.5 to 1.0 mL of decarboxylated sublingual oil or a few puffs from the vape cartridge.
• Sleep Support: Consider 1.0 to 2.0 mL of sublingual oil before bed, delivering 25 to 50 mg of CBN.
• Anxiety and Stress: Start with 0.3 mL of raw sublingual oil for daytime use. For evening use, consider 1.0 mL of sublingual oil or a few puffs from the vape cartridge.
• Chemotherapy-Related Nausea: Consider 0.5 to 1.0 mL of sublingual oil approximately 1 hour before treatment. For acute breakthrough nausea, the vape cartridge provides immediate relief.

3. Listen to Your Body

Everyone’s endocannabinoid system is unique, and individual responses to cannabinoids can vary significantly. Pay attention to how you feel and adjust your dose accordingly.

4. Consult a Healthcare Provider

Before using OilWell RSO—or any cannabinoid product—it’s important to consult with a qualified healthcare provider, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Cannabinoids can interact with certain medications, and your healthcare provider can help you determine whether OilWell RSO is a safe and appropriate option for you.

5. Stay Informed About Legal Considerations

While OilWell RSO is legal under federal law and in most states, including Georgia, it’s important to stay informed about the latest regulations and ensure that you’re in compliance with both federal and state laws. The legal landscape for hemp-derived products is still evolving, and it’s crucial to stay up-to-date on any changes that may affect your ability to purchase and use OilWell RSO.

6. Explore the Open-Source Formulas

If you’re unable to afford OilWell’s products, our open-source formulas provide a way to make your own RSO at home. This ensures that no one is left behind and that everyone has access to the information they need to explore the potential benefits of cannabis.

7. Take Advantage of Our Customer Support

At OilWell Cannabis, we’re committed to providing exceptional customer support. If you have any questions about our products, dosing, or how to use them, our team is here to help. You can reach us by phone at (832) 416-2816 or by email at [email protected].

Why OilWell RSO Stands Out in Georgia’s Cannabis Market

Georgia’s cannabis market is evolving, but it still presents challenges for consumers seeking high-quality, full-spectrum products. Here’s why OilWell RSO stands out as a top choice for Georgians:

1. Evidence-Informed Formulation

Our RSO formula is anchored in the latest scientific research, with each cannabinoid and terpene selected for its potential therapeutic benefits. This evidence-informed approach ensures that our products are designed to provide the most comprehensive and effective experience possible.

2. Patient-Controlled Potency

Our unique THCa formulation allows Georgians to choose between non-psychoactive and psychoactive use, depending on their needs and preferences. This patient-controlled potency is a game-changer for those who need to manage symptoms without impairment during the day.

3. Solvent-Free Production

Our solvent-free production process eliminates the risk of residual solvents, ensuring that our products are safe, clean, and free from harmful contaminants.

4. Third-Party Lab Testing

We subject our products to rigorous third-party lab testing, covering cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request, providing transparency and peace of mind.

5. Open-Source Formulas

Our commitment to accessibility means that we publish our complete RSO formulas, allowing Georgians to make their own RSO at home if they can’t afford our products. This open-source approach ensures that no one is left behind.

6. Nationwide and International Shipping

We ship our products nationwide and internationally, ensuring that Georgians can access our products regardless of where they live. Our discreet packaging and fast shipping options make it easy to get the products you need, when you need them.

7. Exceptional Customer Support

Our team is committed to providing exceptional customer support, helping Georgians navigate the complexities of cannabis use and find the products that work best for them.

8. Community Commitment

From our $35,000 COVID vaccine giveaway to our proactive removal of Delta-8 products during a regulatory crisis, OilWell Cannabis has demonstrated a deep commitment to community health and well-being. We believe in using our platform to make a positive impact, and we’re proud to serve the Georgia community.

The Future of RSO in Georgia: A Vision of Access and Innovation

As Georgia’s cannabis landscape continues to evolve, OilWell Cannabis is committed to leading the way with innovative, evidence-informed products that meet the needs of Georgians. Here’s our vision for the future of RSO in Georgia:

1. Expanding Access to High-Quality Products

We believe that every Georgian should have access to high-quality, full-spectrum cannabis products. That’s why we’re committed to expanding our distribution network and making our products available in more locations across the state.

2. Advancing Cannabis Education

Education is key to ensuring that Georgians can make informed decisions about their health and wellness. We’re committed to providing accurate, up-to-date information about cannabis and its potential benefits, helping to dispel myths and misconceptions.

3. Supporting Research and Innovation

We believe in the power of research to unlock the full potential of cannabis. That’s why we’re committed to supporting scientific studies and collaborating with researchers to advance our understanding of cannabinoids and their therapeutic applications.

4. Advocating for Policy Change

We’re committed to advocating for sensible cannabis policies that prioritize patient access, safety, and innovation. By working with policymakers, healthcare providers, and advocacy groups, we aim to create a regulatory environment that supports the growth of the cannabis industry in Georgia.

5. Building a Community of Support

At OilWell Cannabis, we believe in the power of community. We’re committed to building a network of support for Georgians who use cannabis for health and wellness, providing resources, education, and a platform for sharing experiences.

Final Thoughts: Empowering Georgians with the Best Possible Version of RSO

At OilWell Cannabis, we believe that Georgians deserve the best possible version of RSO—one that combines the traditional benefits of full-spectrum cannabis with modern scientific advancements, rigorous testing, and complete transparency. Our mission is to provide Georgians with the tools they need to take control of their health and wellness, empowering them to make informed decisions about their care.

Whether you’re exploring RSO for the first time or you’re a seasoned cannabis user, we’re here to support you on your journey. From our evidence-informed formulations to our open-source formulas, from our solvent-free production to our exceptional customer support, we’re committed to providing Georgians with the highest-quality products and the most accurate information available.

Thank you for trusting OilWell Cannabis as your partner in health and wellness. We look forward to serving you and helping you discover the potential benefits of RSO in Georgia.

Ready to experience the OilWell difference? Visit our website to learn more and place your order today. If you have any questions, our team is here to help—contact us at (832) 416-2816 or [email protected].

---